Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial
Folegatti, Pedro M, Bittaye, Mustapha, Flaxman, Amy, Lopez, Fernando Ramos, Bellamy, Duncan, Kupke, Alexandra, Mair, Catherine, Makinson, Rebecca, Sheridan, Jonathan, Rohde, Cornelius, Halwe, Sandro,Journal:
The Lancet Infectious Diseases
DOI:
10.1016/S1473-3099(20)30160-2
Date:
April, 2020
Fichier:
PDF, 1.40 MB
2020
File converter
Plus de résultats de recherche
More benefits 
